Applied Therapeutics, Inc. Deferred Tax Assets, Net of Valuation Allowance
Applied Therapeutics, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $870.00 thousand as of 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2025-04-15
- 2024-12-31: Deferred Tax Assets, Net of Valuation Allowance $870.00K.
- 2023-12-31: Deferred Tax Assets, Net of Valuation Allowance $139.00K.
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $272.00K.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $409.00K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2024-12-31 | $870.00K 10-K · filed 2025-04-15 |
| 2023-12-31 | $139.00K 10-K · filed 2025-04-15 |
| 2022-12-31 | $272.00K 10-K · filed 2024-03-06 |
| 2021-12-31 | $409.00K 10-K · filed 2023-03-23 |
| 2020-12-31 | $533.00K 10-K · filed 2022-03-10 |
| 2019-12-31 | $705.00K 10-K · filed 2021-03-18 |